The review, registered prospectively on PROSPERO and updated through repeated searches in June 2024, April 2025 and May 2026, cast a deliberately wide net. The researchers included quantitative intervention studies involving adults with longstanding and severe eating disorders, with no restrictions on diagnosis, type of intervention or treatment setting. After screening, they identified seventeen main empirical studies, reported across twenty publications, together with eight additional case reports or case studies. The dominant participant profile was female, and the dominant diagnosis was anorexia nervosa, reflecting the composition of the severe and enduring eating disorder population as it presents in specialist services. Crucially, most of the included studies reported real-world clinical data drawn from actual treatment services rather than from tightly controlled trial environments, which gives the synthesis an unusually strong ecological validity even as it exposes the fragility of the underlying evidence base.

The interventions examined spanned the full breadth of modern practice. Specialist inpatient treatment programs, high-calorie re-alimentation protocols, integrated pathways built around enhanced cognitive behavioral therapy, standalone outpatient care, digital and virtual transition support, pharmacological treatments, neuromodulation and even neurosurgery all came under scrutiny. Yet despite this breadth of therapeutic activity, the review found only two level II randomized controlled trials in the entire literature. One of those trials tested whether adding a low-intensity digital self-management program after intensive treatment could sustain recovery, and found no added benefit. The other, conducted in a small inpatient sample of patients with eating disorders and comorbid post-traumatic stress disorder, reported preliminary benefits from adjunctive infra-low frequency neurofeedback. The scarcity of randomized evidence for one of psychiatry’s highest-morbidity populations is itself one of the most striking findings of the review.

Against that limited trial evidence, the level III cohort studies told a more coherent story. Specialist inpatient treatment and intensive integrated care pathways were consistently associated with improvements in body mass index, eating disorder psychopathology, broader psychological symptoms, day-to-day functioning and, where it was assessed, quality of life. The clearest signal of benefit, the authors report, emerged from integrated pathways that combined collaborative psychological treatment, weight restoration into the normal range, and continuity of care across different levels of the health system, from inpatient admission through to supported outpatient follow-up. In other words, it was not any single therapeutic ingredient but the combination and the continuity that appeared to drive recovery in this hardest-to-treat group.

Perhaps the most consequential clinical insight from the synthesis concerns what does and does not predict outcome. Duration of illness, long treated as a proxy for hopelessness, was not a consistent predictor of how patients fared. What mattered far more was discharge body mass index within the healthy range, which was associated with good outcomes at follow-up. That single observation carries an enormous practical weight: it reframes the therapeutic goal from simply managing an incurable condition toward actively achieving and maintaining physiological restoration as the foundation for psychological recovery. Standalone outpatient treatment and low-intensity digital transition support, by contrast, showed only limited benefits in this population, suggesting that severely unwell adults may require more intensive, structured and supervised care than routine community services typically provide.

The less conventional arms of the evidence base were far less encouraging. Studies of pharmacological interventions, neuromodulation techniques and neurosurgical procedures were small, largely uncontrolled, and produced inconsistent effects on the core outcomes that matter in eating disorders, such as weight restoration, reduced food-related anxiety and normalized eating behavior. For a field in which deep brain stimulation and experimental pharmacotherapy occasionally generate dramatic headlines, the review’s sober verdict functions as an important corrective: the most reliable gains currently come from well-organized, multidisciplinary clinical care, not from technological interventions that remain at an experimental stage.

The authors are candid about the limitations of the literature they synthesized. This is a heterogeneous patient group with high rates of psychiatric and medical comorbidity, yet many studies provided little information on ethnicity, socioeconomic background, comorbid conditions or the legal treatment status of participants. Definitions of what constitutes longstanding or severe eating disorder varied across studies, making direct comparison difficult. Observational designs dominated, follow-up periods were generally short, and reporting of outcomes that patients and families prioritize, including quality of life, relapse, readmission and treatment acceptability, was inconsistent. These weaknesses do not undermine the central conclusion that improvement is possible, but they do mean clinicians and policymakers must interpret the magnitude and durability of those improvements with appropriate caution.

The implications reach well beyond academic debate. In several countries, including the United Kingdom, insurers and health systems have at times restricted access to intensive eating disorder treatment for patients judged to have chronic, unremitting illness, on the reasoning that prolonged disease duration predicts poor response. By showing that illness duration alone does not forecast outcome, while achieving a healthy weight and sustained psychological support does, the review provides an evidence-based argument for expanding rather than rationing access to integrated care. It also aligns with the growing involvement of people with lived experience in eating disorder research; the author team itself includes a peer researcher with lived experience, and the authors call for future studies to prioritize lived-experience perspectives alongside comorbidity, legal status and continuity of care.

The review’s agenda for future research is explicit. The authors call for standardized definitions and outcome reporting so that studies can be compared and pooled, for implementation research that examines how integrated pathways can be scaled in real health systems, for longer follow-up periods that capture relapse and sustained recovery, and for trials that deliberately include the comorbidities and legal complexities that characterize real clinical populations. Until that evidence arrives, the message for patients, families and clinicians is one of qualified hope. Adults whose eating disorders have endured for years are not beyond help. The treatment that works best is demanding, multidisciplinary and continuous, combining nutritional rehabilitation to a healthy weight with evidence-based psychotherapy and seamless support after discharge, and the review makes clear that the real barrier to recovery for many patients may not be their diagnosis or its duration, but the assumption that treatment is futile.

Subject of Research: Treatment interventions for adults with longstanding and severe eating disorders

Article Title: Treatment interventions for longstanding and severe eating disorders: an updated systematic review and narrative synthesis

Article References: Ayton, A., Kumar, A., Downs, J., Boniface, S., & Treasure, J. (2026). Treatment interventions for longstanding and severe eating disorders: an updated systematic review and narrative synthesis. Journal of Eating Disorders. https://doi.org/10.1186/s40337-026-01722-7

Image Credits: AI Generated

DOI: 10.1186/s40337-026-01722-7

Keywords: eating disorders, anorexia nervosa, systematic review, CBT-E, nutritional rehabilitation, weight restoration, inpatient treatment, treatment outcomes, integrated care, digital interventions, continuity of care, Journal of Eating Disorders